EGFR and cancer: The KEGG pathway indicated that the differentially expressed proteins were mainly involved in EGFR tyrosine kinase inhibitor resistance, FoxO signaling central carbon metabolism in cancer, and the mTOR signaling pathway (Figure 4E,F, Supplementary Figure S5C,D).